Cargando…
Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans
To address concerns around age-related sensitivity to pyrethroids, a life-stage physiologically based pharmacokinetic (PBPK) model, supported by in vitro to in vivo extrapolation (IVIVE) was developed. The model was used to predict age-dependent changes in target tissue exposure of 8 pyrethroids; de...
Autores principales: | Mallick, Pankajini, Moreau, Marjory, Song, Gina, Efremenko, Alina Y, Pendse, Salil N, Creek, Moire R, Osimitz, Thomas G, Hines, Ronald N, Hinderliter, Paul, Clewell, Harvey J, Lake, Brian G, Yoon, Miyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944222/ https://www.ncbi.nlm.nih.gov/pubmed/31593217 http://dx.doi.org/10.1093/toxsci/kfz211 |
Ejemplares similares
-
Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids
por: Mallick, Pankajini, et al.
Publicado: (2020) -
Considerations for Improving Metabolism Predictions for In Vitro to In Vivo Extrapolation
por: Moreau, Marjory, et al.
Publicado: (2022) -
Exposure
Publicado: (2020) -
PBPK Model for Atrazine and Its Chlorotriazine Metabolites in Rat and Human
por: Campbell, Jerry L., et al.
Publicado: (2016) -
Using exposure prediction tools to link exposure and dosimetry for risk-based decisions: A case study with phthalates
por: Moreau, Marjory, et al.
Publicado: (2017)